Acute Treatment Optimization in Episodic and Chronic Migraine: Results of the <scp>A</scp> merican <scp>M</scp> igraine <scp>P</scp> revalence and <scp>P</scp> revention ( <scp>AMPP</scp> ) Study

201551 citationsJournal Article

Authors

Daniel Serrano · Health Outcomes Solutions (United States)

Dawn C. Buse · Albert Einstein College of Medicine

Aubrey Manack Adams · Allergan (United States)

Michael L. Reed · Vedanta Resources (India)

Richard B. Lipton · Montefiore Medical Center

Abstract

Estimates of the latent variable scores for the mTOQ-6 revealed persistent low levels of treatment optimization for both EM and CM, though treatment optimization is worse for CM.

Topics & Keywords

Migraine and Headache Studies Psychosomatic Disorders and Their Treatments Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Headache The Journal of Head and Face Pain

Volume 55, Issue 4, pp. 502-518

DOI: 10.1111/head.12553

Field-Weighted Citation Impact: 2.31